key: cord-0818606-13cotyfb
authors: Shi, Ting; McLean, Kenneth; Campbell, Harry; Nair, Harish
title: Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta–analysis
date: 2015-06-17
journal: Journal of global health
DOI: 10.7189/jogh.05.010408
sha: 4277d45726b61850deb6a0a4b2cabe450127ec69
doc_id: 818606
cord_uid: 13cotyfb

BACKGROUND: Acute lower respiratory infection (ALRI) remains a major cause of childhood hospitalization and mortality in young children and the causal attribution of respiratory viruses in the aetiology of ALRI is unclear. We aimed to quantify the absolute effects of these viral exposures. METHODS: We conducted a systematic literature review (across 7 databases) of case–control studies published from 1990 to 2014 which investigated the viral profile of 18592 children under 5 years with and without ALRI. We then computed a pooled odds ratio and virus–specific attributable fraction among the exposed of 8 common viruses – respiratory syncytial virus (RSV), influenza (IFV), parainfluenza (PIV), human metapneumovirus (MPV), adenovirus (AdV), rhinovirus (RV), bocavirus (BoV), and coronavirus (CoV). FINDINGS: From the 23 studies included, there was strong evidence for causal attribution of RSV (OR 9.79; AFE 90%), IFV (OR 5.10; AFE 80%), PIV (OR 3.37; AFE 70%) and MPV (OR 3.76; AFE 73%), and less strong evidence for RV (OR 1.43; AFE 30%) in young children presenting with ALRI compared to those without respiratory symptoms (asymptomatic) or healthy children. However, there was no significant difference in the detection of AdV, BoV, or CoV in cases and controls. CONCLUSIONS: This review supports RSV, IFV, PIV, MPV and RV as important causes of ALRI in young children, and provides quantitative estimates of the absolute proportion of virus–associated ALRI cases to which a viral cause can be attributed.

Streptococcus pneumoniae and Haemophilus influenza type b (Hib) have been established as the principal aetiological agents of pneumonia -together thought to cause over 50% of all severe ALRI cases in developing countries [5] . The childhood vaccination programme against these bacteria [6] is associated with a substantial reduction in morbidity and mortality from ALRI [7] . Continued research is required to further understand the role of other ALRI pathogens, such as viruses.

Respiratory viruses are implicated, either directly, or as synergistic pathogens or co-factors in bacterial superinfections, in up to two thirds of all cases of pneumonia (equating to 80 million cases in young children in 2010) [2, 8] . Respiratory syncytial virus (RSV) is the most commonly identified virus in young children with ALRI, contributing to an estimated 33.8 million new cases globally in 2005 [9] . Also, at least 25 other viruses have been associated with ALRI in children, most notably -rhinovirus, influenza, human metapneumovirus (MPV) and parainfluenza viruses (PIV) [8] . However, their aetiological role in ALRI in young children remains uncertain and we are not aware of any systematic reviews currently published that investigate this.

Therefore, it is important to understand these viruses' contribution to ALRI. We aimed to conduct a systematic review to identify all case-control studies investigating the potential role of respiratory viruses in the aetiology of acute lower respiratory infections in children younger than five years of age.

We conducted and reported a systematic review according to the PRISMA guidelines. We used tailored strategies to search Medline, Embase, Global Health, LILACS, China National Knowledge Infrastructure (CNKI), Wanfang Data and Chongqing VIP databases (Online Supplementary Document). We further hand-searched the table of contents of specialist journals -the Influenza and Other Respiratory Viruses and Pediatric Infectious Diseases Journal -and the reference lists of relevant papers for eligible articles. All searches were limited to between 1 January 1990 and 4 April 2014, and there were no publication status or language restrictions applied.

We included studies that fulfilled our strict eligibility criteria: studies in children younger than five years; studies investigating clinical pneumonia (or lower respiratory infection) as the primary outcome; studies where respiratory specimens were collected and diagnostic test conducted using valid laboratory tests; case-control studies / prospective cohort studies that reported data in both case and control groups; reporting virus-specific proportions separate-ly in both groups; studies published between 1 January 1990 and 4 April 2014 (19 March for Chinese databases). We only included studies where the case definition for ALRI (or clinical pneumonia) was clearly defined and consistently applied.

Two investigators (TS and KM) conducted independent English language literature searches and extracted data using standardised data extraction templates. One investigator (TS) whose first language is Chinese performed the search and data extraction from Chinese language databases (CNKI, Wanfang and CQVIP). Any discordance and/or uncertainties regarding relevance or inclusion were arbitrated by HN or HC.

We used "ALRI" as an equivalent to clinical pneumonia as our case definition, which also included bronchiolitis. This was to recognise this common manifestation in young children with viral ALRI [10] , and the limits of the WHO case definition to reliably differentiate these [1] . ALRI was characterized as cough or dyspnoea with age-related tachypnoea, while severe ALRI was defined as those with cough or dyspnoea with indrawing of the lower chest wall [11] , or an acute respiratory infection severe enough to necessitate hospitalisation. The control groups were defined as asymptomatic (with no respiratory symptoms), healthy (asymptomatic with no other symptoms) or upper respiratory tract infection (URTI) (with respiratory symptoms).

We standardised the results of all the included studies as odds ratios (ORs) with accompanying 95% confidence intervals (95% CIs), to facilitate interpretation and comparison. We applied a continuity correction of 0.0005 if a virus was detected in one group, but not the other [12] . This allowed calculation of an OR for these instances, and enabled inclusion within subsequent meta-analyses. Furthermore, matched (mOR) and adjusted (aOR) odds ratios were also extracted, where possible. These were used preferentially in subsequent calculations and analyses.

Using STATA (version 11.2), we performed a meta-analysis of virus-specific ORs and reported pooled estimates with corresponding 95% CIs using the random effects model (DerSimonian-Laird method) because these studies do not share common effect size due to methodological heterogeneity [13] . The virus-specific attributable fraction among the exposed (AFE) was used to explore the etiological role of each virus in ALRI patients. This estimates the percentage of (severe) ALRI which can be attributed to each virus, in absolute terms [14] , and was calculated as AFE=100 × (OR-1)/OR with 95% CIs (from the corresponding OR 95% CIs).

Thus, the percentage of all ALRI cases caused by a given virus can be calculated as overall percentage of ALRI cases positive for that virus multiplied by AFE (adjusted percentage (%a) = crude percentage (%c) × AFE), as used in previous work [15] .

We identified 3619 records through literature search of which only 23 studies fulfilled our strict eligibility criteria (Figure 1 ) . Fifty-six studies were excluded for a variety of reasons including: no data specific to children under 5 years old (n=10), not fulfilling the case or control definitions (n=5), no applicable data reported for cases and controls (n=32) and other reasons (n=9). The 23 included studies were primarily conducted within developing countries (n=19) ( Table 1) . Among them, 4 unduplicated papers were from one research group in Thailand [20, 22, 24, 37] . And most of the studies have been conducted since 2003 (n=20).

All included studies were case-control studies with an ALRI and asymptomatic/URTI groups; however some variations were still present. Of the case definitions employed, most used ALRI/ARI (n=13), while others used (severe) pneumonia (n=8), SARI (n=1) or bronchiolitis (n=1). All studies used control group which had no respiratory symptoms, of which 10 were considered otherwise "healthy", and 2 studies [23, 25] also reported URTI as control group. Of the case ascertainment used, all articles contained inpatient data. Among them, 3 studies also provided outpatient data [19, 21, 25] . Twenty controls were ascertained in hospital-based outpatient/clinic sites while 3 were identified in community [15, 17, 25] .

Regarding to sampling methodology, most studies used nasopharyngeal swab (NPS) (n=10), nasopharyngeal aspirate (NPA) (n=6) and nasopharyngeal wash (NPW) (n=1) as specimen. Five studies used mixed specimens including NPA, NPS, lung aspirate and oropharyngeal swab (OPS). All studies used PCR as diagnostic testing except one study from Gambia [16] , in which case indirect immunofluorescence (IIF) was applied.

Meta-analyses of virus-specific ORs were reported as well as the corresponding attributable fractions among the exposed ( Table 2) . RSV, IFV (including IFV A), PIV, MPV and RV were significantly more common in children hospitalized with ALRI than asymptomatic controls (OR (95% CI): 9.79 (4.98-19.27), 5.10 (3.19-8.14), 3.37 (1.59-7.15), 3.76 (2.45-5.78) and 1.43 (1.03-1.97), respectively). Thus, these viruses had statistically significant positive AFEs, which show clear associations between these viruses and ALRI hospitalization in young children. Therefore, this indicates the potential for substantive reductions in the number of ALRI cases were young children to be vaccinated against these viruses. In comparison, AdV, BoV and CoV were frequently detected in control children, and so did not have significantly positive AFEs. Therefore, their roles in ALRI hospitalisation were uncertain.

Sensitivity analyses were also performed to investigate the effect of inclusion of symptomatic (URTI) controls, and of outpatient ALRI cases ( Table 2) . Data on inclusion of outpatient cases had little impact on the associations observed. However, this does not necessarily indicate similarity between the association of inpatient and outpatient ALRI patients. In comparison, the inclusion of symptomatic controls had a more substantial influence, which reduced the strength of association with every virus, except AdV and CoV-NL63.

This is the first systematic review to evaluate and summarise the literature surrounding the viral aetiology of ALRI in young children. Our aim was to summarise good qual-ity data on the absolute effects of the viral exposure and hence to inform causal inference in ALRI aetiological studies which report respiratory viral data. Our review summarises data from 18 592 cases of ALRI in young children reported across 23 studies. We demonstrated stronger evidence (defined here as a statistically significant OR >3) in support of a causal attribution when a virus is identified in young children presenting with ALRI for RSV (OR 9.59-9.79; AFE 90%), IFV (OR 5.10-5.54; AFE 80%), PIV (OR 3.37-4.07; AFE 70%) and MPV (OR 3.76-3.84; AFE 73%). There was less strong evidence (defined here as a statistically significant OR 1-3) for RV (OR 1.43; AFE 30%). There was no statistically significant difference between viral identification in ALRI cases and controls for the other respiratory viruses studied: AdV, BoV, CoV.

These findings should inform the results of studies which seek to estimate the global / regional / national burden of disease due to these viruses. They support the role of RSV, IFV, PIV and MPV as important causes of ALRI in young children (although disease burden estimates should take into account the AFE estimates that we report -thus the true global burden of RSV/IFV/PIV/MPV pneumonia may be 90%/80%/70%/73% of the values reported in recent Table 2 . The meta analyses of the odds ratios (OR) and attributable fraction in the exposed (AFE) of each virus and its subtype within included studies of inpatient (IP) ALRI cases relative to asymptomatic controls ViruS metA AnAlySeS* SenSitiVity AnAlySeS* publications). Applying these estimates to the burden of severe (hospitalised) pneumonia in 2010 [38] , we estimate that the likely true burden of RSV and influenza associated ALRI for that year would be about 2.9 (95% CI 1.5-5.5) million and 0.8 (0.3-2.2) million respectively. There is considerable international attention on RSV and IFV pneumonia in young children at this time when novel vaccine strategies are being evaluated and prioritised and more accurate disease burden estimates (using these results) would help inform future policies and interventions.

Several methodological issues could affect our results: case ascertainment, case definition, clinical specimen and confounding. Twenty-two of the 23 studies used passive hospital-based case ascertainment. Several previous studies have shown that children in developing countries, particularly those residing in rural areas, have in general, limited access to healthcare [39] , and health care seeking behaviour is often delayed or absent [40] [41] [42] . This potentially introduced a selection bias. Similarly, only three studies used community based controls [15, 19, 25] . Hospital ascertained controls may not reflect the general population, and may have other health conditions potentially affecting their viral carriage, especially those with URTI. The ideal control group for these studies would be a random sample of an age and sex matched child population from the same area of residence studied at the same time. Studies, however, recruited controls who were either selected as healthy (asymptomatic) and so biased in favour of those not exposed to the respiratory virus (yielding a falsely high OR) or those who were selected to have respiratory symptoms and so biased in favour of those who had been exposed to the respiratory virus (yielding a falsely low OR). Consistent with this interpretation, we found ( Table 2 ) odds ratios (of ALRI given viral identification) to be consistently greater where the control group were "healthy" and asymptomatic rather than symptomatic (URTI). We consider that the value of the OR based on a population-based control group as described above would lie between these two values.

Seven of the included studies [17, [20] [21] [22] [23] 25, 36] employed the WHO case definition for pneumonia [43] and this standardised approach enhanced the comparability of results between these studies. These criteria have high sensitivity for pneumonia [44] , but lower specificity with overlap with other conditions [45] , particularly malaria [46] and wheezing disorders. This tends to inflate the number of "cases" and may contribute to an apparent low level of detection of pathogenic viruses.

All included studies obtained upper respiratory tract specimens (i.e. described as nasopharyngeal secretions, nasopharyngeal wash samples, nasopharyngeal aspirate samples, oropharyngeal samples). Although their differing sensitivities could result in some heterogeneity [47, 48] , they are broadly comparable and have common flaws. As viruses identified could be from a coincidental URTI in ALRI cases, the sole use of these specimens can only provide supportive evidence for causality. Lung aspiration is considered the gold-standard sampling technique given it is directly obtained from the infection site [49] , which would indicate aetiological significance in ALRI. However, its invasive nature and rate of complications limit its use.

Several potential confounding factors could have distorted the observed associations. Only three studies calculated appropriately adjusted ORs to account for confounding effects from age [24] , or age and season [21, 23] . Instead, matching of cases and controls was more commonly usedperformed by age [16, 18, 19, 25] , or age and month [23, 34] . Nevertheless, despite the use of matching, no studies maintained this pairing to allow OR meta-estimate calculation. While all studies were conducted on young children (under 5 years), six [15, 17, 25, 26, 31, 32] were further restricted. As age is an ALRI risk factor [50] , this could potentially affect the viral profile detected, introducing further heterogeneity. However, no enough data were provided to estimate the strength of association in narrower age bands.

In addition, multiple aetiological agents may often be identified in young children with ALRI, making the individual contribution of each agent difficult to define. Many of the included studies did not provide virological data that excludes coinfections, so viruses detected in these cases could conceivably fulfil any etiological role. The high sensitivity of polymerase chain reaction (PCR) is important for accurate assessment of aetiological contribution. However, the high rates of viral co-infection detection may overstate the individual contribution [8] .

Furthermore, any viruses detected could be from a nascent infection or persistent from a previous infection [51] . These could explain more 'pathogenic' viruses (such as RSV) being identified in asymptomatic children. Some viruses are detectable for weeks before and after ALRI, [52] [53] [54] and so the studies only assessing asymptomatic status without considering past or future history may yield false positive findings [16, 17, 23, 32, 36] .

Moreover, the small sample size [16, 25, 31] , undoubtedly contributed to the imprecise 95% CIs in Table 2 . This may have also led to the non-detection of statistically significant ALRI-virus associations as in some case and/or control groups. Two studies [15, 17] included children of Inuit ancestry from USA or Canada and were found to have high ALRI incidence. The viral associations observed in these two studies may not be generalizable to other populations.

The use of the AFE allows quantification of the excess percentage of ALRI cases due to exposure in absolute terms [55] . However, it assumes the observed association be-tween the virus (and/or related factors) and ALRI is causal [14] , and, in practice, this will undoubtedly have led to extreme estimations. Furthermore, strict interpretation would entail construal of negative values as indicative of the percentage of ALRI prevented by viral exposure [56] , which is biologically implausible.

A virus (or any pathogen) can be considered to be associated with ALRI when detected with a significantly higher frequency in cases than controls without respiratory symptom (asymptomatic). However, coincidence, while necessary, is insufficient for proof of a causal role between a virus and ALRI [57] . Other alternative explanations must first be refuted before causality can be concluded [58] .

Firstly, the virus could be an "innocent bystander" which is more prevalent in patients with ALRI, but has no causal role. Such an effect may be observed due to immunocompromised status from the true causal infection, or nosocomial infections. Secondly, the virus may be a risk factor for ALRI development, but not itself the primary cause. It has been well established that viral infections predispose to subsequent bacterial infection, although the exact mechanisms are still debated [59, 60] . Indeed, influenza and RSV epidemics are commonly observed to precede those of bacterial pneumonia [61] [62] [63] . Thirdly, the virus may be necessary to cause ALRI, but is not sufficient to do so without the concurrent presence of one or more other causal factors. There are numerous risk factors that have been associated with ALRI, both host and environment [50] . Furthermore, there has been lethal synergism observed in viral-bacterial superinfections [64, 65] . These, singularly or in combination, may provide the opportunity for the respiratory virus to cause ALRI. Fourthly, the virus may be the direct and sole cause of ALRI, with causality yet to be con-firmed. Finally, the virus may be the joint cause of ALRI along with other concurrent viral respiratory infections.

Another essential criterion required for the determination of causality is establishment of the temporal sequence of exposure and outcome [57] . As exposure is investigated after the outcome in case-control studies, these cannot provide this evidence. Therefore, there is a rationale for the conduct of birth cohort studies with routine surveillance of children to track the circulation and course of respiratory viral infections. "Vaccine-probe studies" could be used to gain experimental evidence of each virus as a causal pathogen [66] , although this is limited by vaccine availability of effective vaccines. These would allow conclusive assessment of the burden of ALRI attributable to each virus. Considerations of the causal role of these viruses are further complicated by the fact that a recent respiratory virus infection may have caused temporary immune-suppression leading to a subsequent viral or bacterial infection even though the initial infection can no longer be detected. Influenza viral infections leading to subsequent pneumococcal or staphylococcal respiratory infections have been well described [67] . This may result in an under-estimation of the burden of disease associated with respiratory viral infection.

Notwithstanding these limitations, this review provides clear evidence in favour of the causal role of RSV, IFV, PIV, MPV and to a lesser extent RV in childhood ALRI and presents first estimate of the proportion of ALRI cases that can be attributed to the viral exposure. Aetiological studies which simply report rates of viral identification as causal should make attempt to interpret findings in terms of the proportion of ALRI cases among children in whom a respiratory virus is identified that can be attributed to this viral exposure.

Funding: TS is supported by a scholarship from the China Scholarship Council. HC and HN have received grant funding from Bill and Melinda Gates Foundation (OPP1088499) for this work.

Authorship declaration: HN and HC conceptualised the study. TS and KM conducted the literature review with oversight from HN and HC. All authors participated in data analysis and data interpretation. TS and KM prepared the initial draft of the manuscript. HN and HC contributed to report writing and critically reviewed the manuscript. All authors read and approved the final draft of the manuscript.

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from TS). We declare that we have no conflicts of interest.

Global burden of childhood pneumonia and diarrhoea

Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis

Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis

United Nations Children's Fund, World Health Organization. Pneumonia: The forgotten killer of children. Geneva: WHO

World Health Organization. Global vaccine action plan 2011-2020. Geneva: WHO

What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries

Viral pneumonia

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

World Health Organization. Technical bases for the WHO recommendations on the management of pneumonia in children at first-level health facilities

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

Introduction to meta-analysis Chichester

Attributable risk percent in case-control studies

Viral respiratory infections in hospitalized and community control children in Alaska

The etiology of pneumonia in malnourished and well-nourished Gambian children

Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children : a case-control study

Viral etiology of severe pneumonia among Kenyan infants and children

Epidemiology of respiratory syncytial virus infection in rural and urban kenya

Human Coronavirus Infections in Rural Thailand: A Comprehensive Study Using Real-Time Reverse-Transcription Polymerase Chain Reaction Assays

Viral and bacterial causes of severe acute respiratory illness among children aged less than 5 years in a high malaria prevalence area of western Kenya

Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand

A preliminary study of pneumonia etiology among hospitalized children in Kenya

Incidence and etiology of acute lower respiratory tract infections in hospitalized children younger than 5 years in rural Thailand

Respiratory viruses in Nepalese children with and without pneumonia: a case-control study

Clinical analysis of human bocavirus associated with bronchiolitis

High human bocavirus viral load is associated with disease severity in children under five years of age

Viral pathogens of acute lower respiratory tract infection in hospitalized children from East Guangdong of China

Burden of human metapneumovirus infection in young children

Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children

Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values

Human bocavirus infections in hospitalized children and adults

Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls

Clinical utility of PCR for common viruses in acute respiratory illness

Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections

Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children

Human rhinovirus infections in rural Thailand: Epidemiological evidence for rhinovirus as both pathogen and bystander

Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries

Public health in developing countries

Health-care-seeking behaviour for childhood illnesses in a resource-poor setting

Health-seeking patterns among participants of population-based morbidity surveillance in rural western Kenya: implications for calculating disease rates

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance

World Health Organization. Handbook: IMCI Integrated management of childhood illness

Pneumonia research to reduce childhood mortality in the developing world

Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings

World Health Organization. The overlap in the clinical presentation and treatment of malaria and pneumonia in children : report of a meeting. Geneva: World Health Organization

Improved detection of respiratory viruses in pediatric outpatients with acute respiratory illness by real-time PCR using nasopharyngeal flocked swabs

Added Value of an Oropharyngeal Swab in Detection of Viruses in Children Hospitalized with Lower Respiratory Tract Infection

Specimen Collection for the Diagnosis of Pediatric Pneumonia

Epidemiology and etiology of childhood pneumonia

Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections

Persistence of Rhinovirus and Enterovirus RNA After Acute Respiratory Illness in Children

Picornavirus Infections in Children Diagnosed by RT-PCR During Longitudinal Surveillance With Weekly Sampling: Association with Symptomatic Illness and Effect of Season

Incubation periods of acute respiratory viral infections: a systematic review

Conceptual problems in the definition and interpretation of attributable fractions

Proportion of disease caused or prevented by a given exposure, trait or intervention

The Environment and Disease: Association or Causation?

Causal thinking in the health sciences: Concepts and strategies in epidemiology

Respiratory viruses predisposing to bacterial infections: role of neuraminidase

New Look at an Old Problem: Bacterial Superinfection after Influenza

How do viral infections predispose patients to bacterial infections?

Respiratory viral infection predisposing for bacterial disease: a concise review

Viral potentiation of bacterial superinfection of the respiratory tract

Viral and bacterial interactions in the upper respiratory tract

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

Use of vaccines as probes to define disease burden

Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection